Lv4
690 积分 2025-03-28 加入
Effect on Lipoprotein(a) Oxidized Phospholipids of Lepodisiran, an Extended-Duration siRNA Targeting Lipoprotein(a)
16天前
已完结
Biomarker Analysis Reveals Antifibrotic and Anti-inflammatory Signatures in Idiopathic Pulmonary Fibrosis Patients Treated With INS018_055, an AI-discovered TNIK Inhibitor, in a 12-week Phase 2a Study
19天前
已完结
JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib
2个月前
已完结
Safety, tolerability, and pharmacokinetics of single oral doses of tofacitinib, a Janus kinase inhibitor, in healthy volunteers
2个月前
已完结
Prevalence of Malnutrition and Micronutrient Deficiencies in Older Adults with Ulcerative Colitis
4个月前
已完结
ESPEN practical guideline on ethical aspects of medical nutrition therapy
4个月前
已关闭
Population Pharmacokinetic Analysis of an Octreotide Depot (CAM2029) in the Treatment of Acromegaly
5个月前
已完结
Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease
5个月前
已完结
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study
6个月前
已完结
Tegoprazan-based versus esomeprazole-based triple therapy plus bismuth for first-line Helicobacter pylori eradication: A nationwide, multicenter, double-blind, double-dummy, randomized controlled trial
6个月前
已完结
皖公网安备34019202002308
